Hormonal Contraceptive Market Report: Trends, Forecast and Competitive Analysis to 2030

Hormonal Contraceptive Trends and Forecast

The future of the global hormonal contraceptive market looks promising with opportunities in the combination hormonal contraceptive and progestin only markets. The global hormonal contraceptive market is expected to reach an estimated $19.8 billion by 2030 with a CAGR of 3.8% from 2024 to 2030. The major drivers for this market are growing awareness regarding hormonal contraception method in emerging economies and surge in investments by the major players for the R&D of novel contraceptive devices.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Hormonal Contraceptive by Segment

The study includes a forecast for the global hormonal contraceptive by method, hormone, and region.

Hormonal Contraceptive Market by Method [Shipment Analysis by Value from 2018 to 2030]:

• Pill
• Intrauterine Device
• Injectable
• Vaginal Ring
• Implant
• Patch

Hormonal Contraceptive Market by Hormone [Shipment Analysis by Value from 2018 to 2030]:

• Combination Hormonal Contraceptive
• Progestin Only

Hormonal Contraceptive Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Hormonal Contraceptive Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies hormonal contraceptive companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the hormonal contraceptive companies profiled in this report include-

• AbbVie
• Afaxys
• Teva Pharmaceuticals Industries
• Bayer
• Organon
• Pfizer
• Agile Therapeutics
• Janssen Pharmaceutical
• Lupin Pharmaceutical
• Pregna International

Hormonal Contraceptive Market Insights

Lucintel forecasts that pill will remain the largest segment over the forecast period due to increasing awareness about the pills.

Within this market, combination hormonal contraceptive will remain larger segment.

APAC is expected to witness the highest growth over the forecast period due to presence of large pool target population and rise in investment by key players in the region.

Features of the Global Hormonal Contraceptive Market

Market Size Estimates: Hormonal contraceptive market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Hormonal contraceptive market size by method, hormone, and region in terms of value ($B).

Regional Analysis: Hormonal contraceptive market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different methods, hormones, and regions for the hormonal contraceptive market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the hormonal contraceptive market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the hormonal contraceptive market size?

Answer: The global hormonal contraceptive market is expected to reach an estimated $19.8 billion by 2030.

Q2. What is the growth forecast for hormonal contraceptive market?

Answer: The global hormonal contraceptive market is expected to grow with a CAGR of 3.8% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the hormonal contraceptive market?

Answer: The major drivers for this market are growing awareness regarding hormonal contraception method in emerging economies and surge in investments by the major players for the R&D of novel contraceptive devices.

Q4. What are the major segments for hormonal contraceptive market?

Answer: The future of the hormonal contraceptive market looks promising with opportunities in the combination hormonal contraceptive and progestin only markets.

Q5. Who are the key hormonal contraceptive market companies?

Answer: Some of the key hormonal contraceptive companies are as follows:

• AbbVie
• Afaxys
• Teva Pharmaceuticals Industries
• Bayer
• Organon
• Pfizer
• Agile Therapeutics
• Janssen Pharmaceutical
• Lupin Pharmaceutical
• Pregna International

Q6. Which hormonal contraceptive market segment will be the largest in future?

Answer: Lucintel forecasts that pill will remain the largest segment over the forecast period due to increasing awareness about the pills.

Q7. In hormonal contraceptive market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness the highest growth over the forecast period due to presence of large pool target population and rise in investment by key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the hormonal contraceptive market by method (pill, intrauterine device, injectable, vaginal ring, implant, and patch), hormone (combination hormonal contraceptive and progestin only), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?